In addition to the warnings/scrutiny provided by, among other agencies, the FDA in the United States towards gadolinium and its potential dangers to patients with kidney problems, officials in other countries are also beginning to warn the public about these same dangers in reaction to the studies and statistics provided by the American medical community.

Recently, Lexi-Comp, Inc. of Canada published a notice that Health Canada, which is generally analogous to the FDA in the United States, is alerting consumers of a notice that had been sent to Canadian hospitals regarding the potential link between gadolinium and the development of NSF/NSD.

In the report, Lexi-Comp stated the following:

Although there have been no reported cases of NSF/NFD in Canada, worldwide there have been 109 cases reported to date. Health Canada is recommending that consumers with serious kidney disease who may be undergoing MRI, discuss their individualized needs with their healthcare provider. Discussions should be aimed at minimizing risks for developing NSF/NFD following imaging procedures. Health Canada, in association with the authorized producers, will be working to update the product labeling.

As can be seen by this report, gadolinium and its potential links to debilitating and even fatal medical consequences is quickly becoming a world-wide problem. If you have been injured as a result of having gadolinium injected into your system, contact the gadolinium lawyers at Williams Kherkher for a free consultation either by using the link provided or by calling 866.950.9000.